Stay updated on KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Sign up to get notified when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2 across the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T07:51:03.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0 from the page; no other content changes were observed.
    Difference
    0.0%
    Check dated 2026-02-05T14:18:22.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    UI text updates include showing the glossary, capitalization changes in QC-related labels, and FEAR Act data and revision notes. These changes do not affect the study details, eligibility criteria, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T07:52:39.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 on the page.
    Difference
    0.0%
    Check dated 2026-01-15T03:05:47.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A consolidated Locations section now lists California, Florida, Massachusetts, and Texas as study sites, replacing the separate location headers, and the page revision has been updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-24T13:48:49.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Publications section text updated to note PubMed auto-population of articles, and the page now displays Revision: v3.3.2. This replaces the earlier wording about PubMed publications and Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:44:40.000Z thumbnail image

Stay in the know with updates to KTE-C19 + Atezolizumab in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KTE-C19 + Atezolizumab in DLBCL Clinical Trial page.